Diabetes
Page 1 • 3 itemsUnlock global diabetes market insights. Get critical pharma intelligence on R&D, regulatory approvals, and investment opportunities for diabetes treatments.
Apotex Receives First Canadian Health Canada Approval for Generic Ozempic (Semaglutide) Alternative
Apotex becomes first Canadian pharmaceutical company to receive Health Canada approval for Apo-Semaglutide Injection, a generic equivalent of Ozempic.
Energenesis Biomedical ENERGI-F703DFU Diabetic Foot Ulcer Treatment Data to Be Presented at EWMA 2026
Energenesis Biomedical will present clinical data for ENERGI-F703DFU gel, a novel topical treatment for diabetic foot ulcers, at EWMA 2026 in Bremen.
Ascletis Pharma to Present Diabetes Drug Data at American Diabetes Association 2026 Scientific Sessions
Ascletis Pharma will present clinical data on multiple diabetes programs at the ADA 2026 Scientific Sessions, showcasing pipeline developments in diabetes treatment.